Since establishing our private equity strategy in 1989, we have invested in over 410 private equity investments in 42 countries.
| Company | Country | Sector | Description | Deal type | Invest. date | |
|---|---|---|---|---|---|---|
 |
GS Capsule | Country Greater China | Sector Healthcare | Description A leading research, development and production company of hard capsules in China. | Deal type Buyout | Invest. date Dec 2021 |
 |
Cohance Lifesciences (formerly RA Chem Pharma Limited) | Country India | Sector Healthcare | Description A vertically integrated API player, also engaged in manufacturing of pellets, B2B formulations and clinical studies | Deal type Buyout | Invest. date Oct 2020 |
 |
Bharat Serums and Vaccines | Country India | Sector Healthcare | Description A biopharmaceutical leader in women's healthcare, assisted reproductive treatment, critical care and emergency medicine in India and emerging markets | Deal type Buyout | Invest. date Feb 2020 |
 |
BioDuro | Country China | Sector Healthcare | Description A leading global life sciences contract research and development organization | Deal type Buyout | Invest. date Jan 2019 |
 |
CARE Hospitals | Country India | Sector Healthcare | Description Largest multi-specialty hospital chain in South and Central India | Deal type Growth equity | Invest. date Mar 2012 |
 |
Thonburi Hospital | Country Thailand | Sector Healthcare | Description Hospital providing general medical care, surgery, intensive care, cardiac care, x-ray and laboratory services | Deal type Growth equity | Invest. date Jul 1994 |
© 2002-2023 Advent International, L.P. All rights reserved
